Cell and Gene Therapy

Alternatives in HD treatment: RNA interference, small molecules, and combination approaches 5:14
Alternatives in HD treatment: RNA interference, small molecules, and combination approaches
Jee Bang • 4 Apr 2022
An outlook on the future therapeutic landscape of MS 4:38
An outlook on the future therapeutic landscape of MS
Ahmed Obeidat • 15 Jun 2022
Cellular therapy in MS 4:51
Cellular therapy in MS
Ahmed Obeidat • 15 Jun 2022
Stem cell therapy to treat acute stroke patients 2:12
Stem cell therapy to treat acute stroke patients
Dileep Yavagal • 3 Apr 2022
Eli-cel gene therapy vs alloHSCT in children with CALD 2:20
Eli-cel gene therapy vs alloHSCT in children with CALD
Christine Duncan • 24 Apr 2022
Ongoing trials with importance for Huntington’s disease 4:24
Ongoing trials with importance for Huntington’s disease
Jee Bang • 4 Apr 2022
Targets in DNA repair machinery for the treatment of Huntington’s disease 2:27
Targets in DNA repair machinery for the treatment of Huntington’s disease
Jee Bang • 4 Apr 2022
Enhancing responses to anti-seizure medications 4:29
Enhancing responses to anti-seizure medications
Matthew Walker • 15 Mar 2022
Ex vivo gene therapy for neurodegenerative diseases 2:20
Ex vivo gene therapy for neurodegenerative diseases
Clive Svendsen • 15 Mar 2022
Therapeutic approaches to target alpha-synuclein in Parkinson’s disease 1:46
Therapeutic approaches to target alpha-synuclein in Parkinson’s disease
Gennaro Pagano • 5 Nov 2021
Update: novel disease-modifying treatments in development for Huntington’s disease 2:20
Update: novel disease-modifying treatments in development for Huntington’s disease
Anne Rosser • 23 Sep 2021
Phase I trial of fetal striatal cell transplantation in Huntington’s disease 2:58
Phase I trial of fetal striatal cell transplantation in Huntington’s disease
Anne Rosser • 23 Sep 2021
Novel treatment strategies for NMOSD 1:21
Novel treatment strategies for NMOSD
Kazuo Fujihara • 4 Oct 2021
Challenges in developing gene-based therapies for neurodegenerative & neuromuscular diseases 3:04
Challenges in developing gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
Approved gene-based therapies for neuromuscular diseases 3:57
Approved gene-based therapies for neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases 13:42
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
The content of VJNeurology is intended for healthcare professionals